Next Article in Journal
Gain-of-Function (GOF) Mutant p53 as Actionable Therapeutic Target
Next Article in Special Issue
Immunosenescence and Immunotherapy in Elderly Acute Myeloid Leukemia Patients: Time for a Biology-Driven Approach
Previous Article in Journal
Regulation of Constitutive Interferon-Stimulated Genes (Isgs) in Tumor Cells Contributes to Enhanced Antitumor Response of Newcastle Disease Virus-Infected Tumor Vaccines
Previous Article in Special Issue
Allogeneic Hematopoietic Cell Transplantation for Older Adults with Acute Myeloid Leukemia
 
 
Review

Article Versions Notes

Cancers 2018, 10(6), 187; https://doi.org/10.3390/cancers10060187
Action Date Notes Link
article xml file uploaded 6 June 2018 13:14 CEST Original file -
article xml uploaded. 6 June 2018 13:14 CEST Update https://www.mdpi.com/2072-6694/10/6/187/xml
article pdf uploaded. 6 June 2018 13:14 CEST Version of Record https://www.mdpi.com/2072-6694/10/6/187/pdf
article html file updated 6 June 2018 13:15 CEST Original file -
article html file updated 25 June 2018 12:00 CEST Update -
article html file updated 30 March 2019 08:13 CET Update -
article html file updated 16 April 2019 08:16 CEST Update -
article html file updated 16 April 2019 13:54 CEST Update -
article html file updated 30 April 2019 13:16 CEST Update -
article html file updated 4 October 2019 08:11 CEST Update -
article html file updated 9 February 2020 20:30 CET Update -
article html file updated 16 July 2022 21:12 CEST Update https://www.mdpi.com/2072-6694/10/6/187/html
Back to TopTop